26 October 2025

Rafael Perdomo, Co-Founder and CEO, Vitae Health & Peter Diaz, Co-Founder and COO, Vitae Health

Read The Article
Rafael Perdomo, Co-Founder and CEO, Vitae Health & Peter Diaz, Co-Founder and COO, Vitae Health
"We built a model that invests in technical capabilities, enabling technology and continuous clinical training so that we can match in-hospital levels of care at home."

Could you give us an overview of the company as it stands today?

Vitae Health is, at its core, a hospital-at-home provider. Founded in 2017, we began by focusing on chronic conditions. That work quickly revealed the global challenges behind chronic disease, many tied to lifestyle and socioeconomic determinants. Some cultures enjoy more balanced diets; across much of Latin America, however, carbohydrate-heavy diets and socioeconomic constraints complicate chronic care. This insight led us to address the primary driver of insurer loss ratios: hospitalization.

We recognized that hospital costs are high, hospital-acquired infection risks are significant, and lengths of stay are often prolonged, making it harder to deliver an exceptional patient experience. We therefore built a model that invests in technical capabilities, enabling technology and continuous clinical training so that, over time, we can match in-hospital levels of care at home. The result is a new, high-value segment that keeps the patient’s experience and safety at the center while directly impacting the core of insurers’ medical loss ratios.

Our offering is a turnkey service that controls every variable that drives clinical effectiveness, patient safety and experience. We manage end-to-end—nursing, medications, equipment and supplies, lab services and therapies—to mirror mid- and high-acuity hospital services at home. To date, we have delivered more than 500,000 services, cared for over 16,000 patients and generated insurer savings in the millions with an average 42 percent cost reduction per case versus hospital care, based on our internal data.

From day one, we knew scale required proprietary technology. Our in-house platform powers operations, administration and clinical workflows: from medical records to logistics, authorizations and billing. Our mobile apps keep the ecosystem connected, so supervising physicians receive real-time updates from nursing teams in the field.

Today, Vitae Health employs more than 3,000 people across the region, partners with over 30 local and international insurers and operates in four markets: Panama, El Salvador, the Dominican Republic and Guatemala.

What are your key success factors?

Beyond putting the patient at the center, we designed an interconnected value proposition for every stakeholder in care: insurers, treating physicians, vendors and our internal and external teams. This ensures the model creates value from every perspective, delivering an exceptional patient experience with tangible benefits for all.

A major early challenge was earning the insurers’ trust. The bar was clear: prove cost savings without compromising clinical quality. We started case by case until the results spoke for themselves. COVID-19 became a turning point amid hospital saturation, and we established ourselves as a trusted alternative for physicians, insurers and patients, managing high volumes and accelerating our growth.

What are the company’s current focus and most impactful solutions?

Our core remains acute hospital-at-home. In parallel, we run hospitalization containment programs for high-risk populations. Through technology, test-and-learn cycles and well-defined inclusion criteria, we intervene early to avoid unnecessary admissions or to transition patients to home care earlier when it is clinically safe.

In cohorts under our care, we have reduced hospitalization rates from a historic 40-45 percent to around 2.3 percent, using blended solutions that combine service delivery, close clinical follow-up and technology. The result is a substantial cost impact and markedly higher satisfaction, especially among clinically vulnerable populations, such as older adults, patients with uncontrolled chronic disease and oncology patients, among others. Our technology is proprietary yet flexible to interoperate with partner platforms, which helps guarantee economic impact.

How does Vitae Health differentiate itself in a digital, competitive landscape?

Our most important differentiator is having proven a new, reliable and safe segment: hospital-at-home as a real alternative that shortens inpatient length of stay or enables early transition to home, maintains high clinical effectiveness and is financially compelling for insurers and operationally practical for treating physicians. Layered on top are our continuously evolving in-house platform and our comprehensive service model that removes logistical burdens for doctors and patients alike.

We are intentionally inclusive and collaborative, working with physicians, pharmaceutical distributors, labs and even hospitals, because in healthcare, impact is built through alliances that protect quality and patient safety.

What are your market development and expansion plans?

The expansion opportunity is significant across Central America, the Caribbean and throughout North and South America. We have amassed millions of clinical data points to stratify populations and design precise plans for complex comorbidities. A priority going forward is scaling impact through strategic partnerships in large markets such as the United States, Mexico and Europe. We deeply respect our peers’ work; our goal is to complement and amplify the impact they already deliver. Larger insurers in these markets also make it easier to create data-driven clusters of at-risk populations, ideal conditions for pilots, innovation and rapid proof of value.

This ties to a global question: how do we keep health systems sustainable as life expectancy rises? Without a disruptive, proven model—ours and others—containing medical costs for aging populations will be difficult. Our approach contributes to sustainability by shifting complex, safe care into the home whenever clinically appropriate.

How do you engage patients, providers and partners?

We prioritize proactive, continuous care: on-time delivery of supplies, medications and equipment, and punctual home visits. When there is a strong nurse-patient rapport, we preserve continuity. For insured patients, we ensure all documentation is ready for coverage.

When we outsource, we do so only with partners who meet stringent standards in punctuality, confidentiality, presentation, courtesy and respect. We hold regular performance reviews, apply satisfaction surveys to both in-house and outsourced services, and conduct 7- and 14-day post-care calls to confirm positive clinical progress.

What’s your key message to Newsweek’s audience?

At Vitae Health, we believe the future of healthcare lies beyond hospital walls. For nearly a decade, we have redefined how complex, high-quality care is delivered: blending clinical excellence, proprietary technology and a deeply patient-centric philosophy. With robust data, a proven operating model and a network of trusted partners, we are ready to scale our impact into new markets and contribute to the sustainability of health systems, especially for populations seeking world-class care without the constraints of traditional hospitalization.